Joanitah Nalunjogi

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 134 citations · Full text

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis, Tuberculosis Prevention +7

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

Joanitah Nalunjogi, Sergio Mucching‐Toscano, Jean Pierre Sibomana et al. · International Journal of Infectious Diseases · 2023 · 35 citations · Full text

Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study

Irene Najjingo, Winters Muttamba, Bruce Kirenga et al. · PLoS ONE · 2019 · 25 citations · Full text

Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda

Joseph Baruch Baluku, Martin Nabwana, Joanitah Nalunjogi et al. · BMC Cardiovascular Disorders · 2022 · 18 citations · Full text

Accuracy and Incremental Yield of the Chest X-Ray in Screening for Tuberculosis in Uganda: A Cross-Sectional Study

Joanitah Nalunjogi, Frank Mugabe, Irene Najjingo et al. · Tuberculosis Research and Treatment · 2021 · 12 citations · Full text

Pulmonary Tuberculosis, Diagnostic Test, Tuberculosis Prevention +14